Chronic Phase of Chronic Myeloid Leukemia: Developed for the American Interferon, and Allogeneic Bone Marrow Transplantation in Treating the An Evidence-Based Analysis of the Effect of Busulfan, Hydroxyurea,
نویسندگان
چکیده
Talpaz and Sante Tura Charles Bennett, John M. Goldman, Francois Guilhot, Hagop M. Kantarjian, Alan E. Lichtin, Moshe Richard T. Silver, Steven H. Woolf, Rüdiger Hehlmann, Frederick R. Appelbaum, James Anderson, American Society of Hematology, December 5, 1998, Miami Beach, FL. Society of Hematology : Presented in part at the Education Session of the Chronic Phase of Chronic Myeloid Leukemia: Developed for the American Interferon, and Allogeneic Bone Marrow Transplantation in Treating the An Evidence-Based Analysis of the Effect of Busulfan, Hydroxyurea,
منابع مشابه
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
Because there are differing opinions regarding treatment of patients in the chronic phase of chronic myeloid leukemia (CML), the American Society of Hematology convened an expert panel to review and document evidence-based benefits and harms of treatment of CML with busulfan (BUS), hydroxyurea (HU), recombinant interferon-alpha (rIFN-alpha), and bone marrow transplantation (BMT). The primary me...
متن کامللوسمی میلوئید مزمن در کودکان و گزارش یک مورد
SUMMARY Chronic Myeloid Leukemia In Children And a Case – Report Dr. Roya Ejte mai , Assistant. professor, Gilan University of medical Sciences, Rasht . The case is a ten-years - old boy. During examinations for massive splenomegaly, his disease has been diagnosed chronic Myelogenous leukemia (CML), and also philadelphia chromosome was revealed during chromosomal analysis. The patient was t...
متن کاملProlonged Administration of Interferon-a in Patients With Chronic-Phase Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Before Allogeneic Bone Marrow Transplantation May Adversely Affect Transplant Outcome
To assess the influence of pretransplant cytoreductive therapy with special reference to interferon-a (IFN-a) treatment on major endpoints of allogeneic bone marrow transplantation (BMT), we studied 133 consecutive patients with Philadelphia chromosome (Ph'l-positive chronic myelogenous leukemia (CML) in first chronic phase who received marrow grafts from HLA-identical family (n = 103) or alter...
متن کاملFractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase.
Ninety-four consecutive patients with chronic myelogenous leukemia in first clinical chronic phase, median age of 34.0 years (range, 6.8 to 52.4 years), with a histocompatible sibling donor, were treated with fractionated total body irradiation (1,320 cGy) and high-dose etoposide (60 mg/kg) followed by allogeneic bone marrow transplantation (BMT). The median time from diagnosis to BMT was 7.0 m...
متن کاملDonor Leukocyte Infusions for Chronic Myeloid Leukemia in Relapse after Allogeneic Bone Marrow Transplantation
Allogeneic bone marrow transplantation (BMT) is the only curative therapy for chronic myeloid leukemia (CML), but relapse occurs in approximately 10% of patients transplanted in chronic phase with non T-cell-depleted marrow.’” The risk of relapse is substantially greater if T-cell depletion of donor marrow is used as prophylaxis against graft-versus-host disease (GVHD), when relapse rates of 50...
متن کامل